Roche expands the Global Access Program beyond HIV to also include diagnostic tests for Tuberculosis, Hepatitis, and Human Papillomavirus

    NEXT STORY
    Sandoz announces first patient enrolled in clinical study for proposed biosimilar denosumab in osteoporosis
    PREV STORY
    Two Decades Of Value Delivery And Partnership In Mali
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Wision AI Announces Publication of Data from the First-Ever Prospective, Randomized Controlled Trial Evaluating the Use of Artificial Intelligence in Advanced Diagnostics

    author_avatar
    NASDAQ Market News

    Coherus BioSciences Completes Patent Dance Exchange with Amgen for Neulasta Biosimilar

    REDWOOD CITY, Calif., April 25, 2017 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), announced ...

    author_avatar
    NASDAQ Market News

    Point of Care Testing Market will surge at 7%+ CAGR to hit $34.2 billion by 2024: Global Market Insights, Inc.

    Biosensors technology segment of point of care testing market exceeded USD 6,404.2 million in ...

    author_avatar
    NASDAQ Market News